Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Amgen
Company Monitoring Page for Amgen
latest headlines for company on cafepharma
Amgen takes next step with its China ambitions, out-licensing drugs to Fosun Pharma
Endpoints
Mon, 06/27/22 - 06:58 pm
Tags:
Amgen
,
China
,
Fosun Pharmaceutical
As biosimilars gain steam, Amgen exec lays out its Humira copycat plans
Fierce Pharma
Wed, 06/22/22 - 06:57 pm
Tags:
Amgen
,
Humira
,
biosimilars
Cytokinetics aims to become the Vertex of cardiovascular disease
EP Vantage
Thu, 06/16/22 - 10:19 am
Tags:
Cytokinetics
,
Amgen
,
heart failure
,
Omecamtiv Mecarbil
,
cardiovascular disease
ASCO 2022 – the spirit of Rova-T struggles to live on
EP Vantage
Tue, 06/7/22 - 10:19 am
Tags:
ASCO 2022
,
Rova-T
,
AbbVie
,
Harpoon Therapeutics
,
Amgen
,
Boehringer Ingelheim
ASCO: It's all tied up? Mirati's KRAS data are 'identical' to Amgen's, researcher says
Fierce Biotech
Mon, 06/6/22 - 10:33 am
Tags:
ASCO 2022
,
Mirati Therapeutics
,
Amgen
,
Lumakras
,
adagrasib
,
lung cancer
Regeneron's cholesterol drug war heats up with lawsuit over Amgen's 'illegal' bundling scheme
Fierce Pharma
Wed, 06/1/22 - 07:36 pm
Tags:
Regeneron
,
Amgen
,
FDA
,
antitrust
,
legal
,
Repatha
,
Praluent
Amgen eyes swift move to ph3 for cardiovascular drug olpasiran
Pharmaforum
Wed, 06/1/22 - 09:33 am
Tags:
Amgen
,
olpasiran
,
Novartis
,
clinical trials
,
cardiovascular disease
Amneal scores third biosimilar approval in three months
Biopharma Reporter
Tue, 05/31/22 - 10:31 am
Tags:
Amneal
,
FDA
,
biosimilars
,
pegfilgrastim
,
Fylnetra
,
Amgen
,
Neulasta
Mirati matches Amgen with updated data for KRAS-blocking cancer drug
BioPharma Dive
Fri, 05/27/22 - 10:15 am
Tags:
Mirati Therapeutics
,
Amgen
,
KRAS
,
adagrasib
,
Lumakras
,
clinical trials
Bristol's Abecma, Amgen's Lumakras headline record-setting oncology launch class as costs continue to balloon: IQVIA
Fierce Pharma
Thu, 05/26/22 - 10:53 pm
Tags:
oncology
,
cancer
,
IQVIA
,
Bristol Myers Squibb
,
Abecma
,
Amgen
,
Lumakras
Could This Biosimilar Drug Candidate Create a Blockbuster for Amgen?
Motley Fool
Mon, 05/23/22 - 06:44 pm
Tags:
Amgen
,
biosimilars
,
Stelara
,
JNJ
Amgen celebrates 25 years of deCODE Genetics as partnership evolves from discovery to development
Fierce Biotech
Fri, 05/20/22 - 10:16 am
Tags:
Amgen
,
M&A
,
deCODE Genetics
,
drug discovery
,
drug development
Bristol Myers on track for 3rd new drug launch of 2022 with latest deucravacitinib data
Fierce Biotech
Thu, 05/12/22 - 10:48 am
Tags:
Bristol Myers Squibb
,
deucravacitinib
,
clinical trials
,
psoriasis
,
Amgen
,
Otezla
The 12 Top Biotech Companies Hiring Now
BioSpace
Tue, 05/10/22 - 10:26 pm
Tags:
biotech
,
life sciences
,
hirings
,
Regeneron
,
Pfizer
,
Amgen
,
AbbVie
,
Moderna Therapeutics
,
CSL Behring
,
Waters Corporation
,
Daiichi Sankyo
,
Gilead Sciences
,
Grail
,
Emergent BioSolutions
,
resilience
Amgen spinout Kezar hits PhII hurdle, all eyes on June readout for drug’s other study
Endpoints
Wed, 05/4/22 - 10:39 am
Tags:
Amgen
,
Kezar Life Sciences
,
zetomipzomib
,
autoimmune disease
,
dermatomyositis
,
polymyositis
Amgen Battles IRS Over Billions in "Wholly Unwarranted" Tax Penalties
BioSpace
Wed, 04/27/22 - 10:47 pm
Tags:
Amgen
,
earnings
,
taxes
,
IRS
A bad day for Molecular Partners
EP Vantage
Wed, 04/27/22 - 10:45 am
Tags:
Molecular Partners
,
MP0310
,
Amgen
,
Novartis
,
ensovibep
Thought CETP inhibition was dead? Think again
EP Vantage
Sat, 04/23/22 - 04:17 pm
Tags:
New Amsterdam
,
Amgen
,
CETP inhibitors
,
obicetrapib
Amgen parts ways with part of Ventura County headquarters campus: report
Fierce Pharma
Thu, 04/14/22 - 10:44 am
Tags:
Amgen
,
California
,
headquarters
Novartis Highlights Early Data from Potential Lumakras Competitor at AACR
BioSpace
Tue, 04/12/22 - 10:49 am
Tags:
Novartis
,
AACR
,
JDQ443
,
clinical trials
,
Amgen
,
Lumakras
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.